Vanguard Health Care ETF (VHT)
| Assets | $15.36B |
| Expense Ratio | 0.09% |
| PE Ratio | 20.85 |
| Shares Out | 87.27M |
| Dividend (ttm) | $3.99 |
| Dividend Yield | 1.61% |
| Ex-Dividend Date | Jun 26, 2025 |
| Payout Ratio | 33.58% |
| 1-Year Return | -7.74% |
| Volume | 257,483 |
| Open | 247.65 |
| Previous Close | 247.30 |
| Day's Range | 246.45 - 249.16 |
| 52-Week Low | 234.11 |
| 52-Week High | 289.14 |
| Beta | 0.67 |
| Holdings | 419 |
| Inception Date | Jan 26, 2004 |
About VHT
Fund Home PageThe Vanguard Health Care ETF (VHT) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care indexThe fund tracks a market-cap-weighted index of US healthcare stocks VHT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
44.83% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.65% |
| AbbVie Inc. | ABBV | 4.99% |
| UnitedHealth Group Incorporated | UNH | 4.95% |
| Johnson & Johnson | JNJ | 4.70% |
| Abbott Laboratories | ABT | 4.15% |
| Intuitive Surgical, Inc. | ISRG | 3.55% |
| Merck & Co., Inc. | MRK | 3.47% |
| Mktliq 12/31/2049 | n/a | 2.80% |
| Boston Scientific Corporation | BSX | 2.79% |
| Amgen Inc. | AMGN | 2.78% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 26, 2025 | $0.9619 | Jun 30, 2025 |
| Mar 25, 2025 | $0.9396 | Mar 27, 2025 |
| Dec 18, 2024 | $0.9188 | Dec 20, 2024 |
| Sep 27, 2024 | $1.1666 | Oct 1, 2024 |
| Jun 28, 2024 | $0.9656 | Jul 2, 2024 |
| Mar 22, 2024 | $0.8189 | Mar 27, 2024 |
News
VHT Looks Attractive, And Risks May Be Overestimated
Healthcare stock valuations are struggling to rise due to political risk and scandals, but this could create attractive entry points for long-term investors. And the reason lies in the bearish narrati...
China Trade Progress: Market Booms On News, Who Will Benefit?
The U.S. and China agreed to reduce tariffs on each other's goods for 90 days, boosting global equity markets and easing trade tensions. U.S. tariffs on Chinese imports will drop from 145% to 30%, whi...
Best blue-chip ETFs to buy as Donald Trump's trade war escalates
American stocks have crashed this year, and are continuing to lag behind their global peers in countries like Germany, France, and China. This performance may continue next week when Trump implements ...
VHT: Strong Growth Outlook, But Still Overpriced
Vanguard Health Care ETF (VHT) is rated a hold due to high valuations and low profitability of top holdings despite strong healthcare sector growth potential. VHT's top holdings, Eli Lilly, UnitedHeal...
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
VHT: A Better Choice For Health Care Assets
VHT is a low-cost index fund providing broad exposure to U.S. health care companies and is currently trading 12% below 52-week lows. The fund tracks the MSCI US IMI Health Care 25/50 Index, encompassi...
VHT: Valuation Is An Issue
VHT offers exposure to 400 healthcare companies and its biggest sector allocations are in biotechnology, pharmaceuticals, and healthcare equipment. It has outperformed the market in the past, showing ...
VHT Is Breaking Out On Healthcare Strength (Technical Analysis)
The healthcare industry shows consistent growth and resilience, driven by medical advancements and aging demographics, making long-term investing in healthcare sensible. VHT offers diversified exposur...
VHT: With Recession Risks Rising, It's Time To Play Defense With Healthcare
Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Jo...
VHT: A Cheap And Easy Way To Access Healthcare
The health care sector shows promising growth and potential for significant returns, dominated by GLP-1 weight loss hype. Vanguard Health Care Index Fund ETF Shares tracks the performance of the MSCI ...
VHT: Well-Positioned Fund In A Promising Sector, But Mediocre Compared To Peers
Vanguard's Health Care ETF has slightly underperformed peer healthcare funds and risks underperforming looking forward due to its current mix of holdings. VHT is broadly diversified, resulting in a lo...
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
Catalyst Watch: Cigna, Humana Deal Would Face Regulatory Hurdles
Economists expect a rise of about 175,000 in non-farm payrolls. Broadcom and Lululemon are set to report earnings, with analysis focused on Broadcom's relationship with Google and Lululemon's success ...
VHT: Current Valuation Not Justified Due To Declining Long-Term Earnings Growth Forecast
VHT offers better downside protection than the broader market but its long-term earnings growth is in a declining trend. VHT's valuation is not attractive relative to the S&P 500 index. Valuation comp...
VHT: Overweight Health Care As It Makes Its Seasonal Dip
Health Care sector has shown recent relative strength in the last month after a poor start to the year versus the S&P 500. Vanguard Health Care sector ETF is recommended with low expense ratio and sol...
XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison
The Health Care Select Sector SPDR ETF and the Vanguard Health Care ETF are the two most popular Health Care ETFs, with a combined $57 billion in assets under management. Both ETFs have a 0.10% expens...
VHT: Why Vanguard's Healthcare ETF Outperformed Last Week
Vanguard's cost-efficient (0.10% expense fee) Health Care ETF is an excellent defensively-oriented fund to hold during challenging economic times. That being the case, the VHT ETF significantly outper...
Vanguard ETFs: Recommendations For 2023
Expert recommendations for choosing among the myriad of Vanguard ETFs may prove to be a valuable resource to investors, even if not all of them will prove right. I present such recommendations made by...
VHT: You Won't Get Defensive Healthcare Exposure Here
Healthcare is considered a defensive sector and due to the brand name and cheap exposure, Vanguard's ETF prima-facie looks like a promising idea. However, outsized exposure to pharmaceuticals and biot...
VHT: 2 Megatrends In Healthcare
An aging population is expected to boost the demand for healthcare over the next few decades. The potential to reduce time and cost using AI in healthcare is an absolute game changer for the industry.
14 High-Yield Blue-Chips Perfect For 2023
The first few months of 2023 could see stocks fall 10% to 23%, and a lot of investors could make disastrous mistakes. Low-volatility high-yield blue-chips are a great way to stay invested and profit f...